World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
31473
World Ranking
13550
National Ranking
6892

H. Ballentine Carter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where H. Ballentine Carter sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 385 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

H. Ballentine Carter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where H. Ballentine Carter sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

H. Ballentine Carter is affiliated with the Johns Hopkins University School of Medicine in the United States. Their professional profile indicates involvement in the academic and medical research community, although specific details about recent publications, co-authors, and research topics are not provided.

There is no available information about any published research papers, including titles, years, or publication venues. Similarly, there is no data regarding frequent co-authors, which suggests that either collaborative patterns are not documented or this information is not accessible.

Details about frequent publication venues or key fields of study are absent, and there is no indication of core subfields or main topics related to their research work. The lack of information about book publications or awards further limits the scope of a detailed academic profile.

Given the current data, it is clear that H. Ballentine Carter maintains an active professional role linked with a major medical institution, which implies involvement in medical education or clinical research, although such activities cannot be confirmed without additional data.

Best Publications

  • The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

    Alan W. Partin;John Yoo;H. Ballentine Carter;Jay D. Pearson

  • Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

    H. Ballentine Carter;Jay D. Pearson;E. Jeffrey Metter;Larry J. Brant;Larry J. Brant

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Overdiagnosis and Overtreatment of Prostate Cancer

    Stacy Loeb;Marc A. Bjurlin;Joseph Nicholson;Teuvo L. Tammela

  • Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia

    Alan W. Partin;H. Ballentine Carter;Daniel W. Chan;Jonathan I. Epstein

  • Complications After Prostate Biopsy: Data From SEER-Medicare

    Stacy Loeb;H. Ballentine Carter;Sonja I. Berndt;Winnie Ricker

  • Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

    Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo

  • Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

    Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll

  • Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

    Jeffrey J. Tosoian;Bruce J. Trock;Patricia Landis;Zhaoyong Feng

  • Prostate Specific Antigen Best Practice Statement: 2009 Update

    Kirsten L. Greene;Peter C. Albertsen;Richard J. Babaian;H. Ballentine Carter

  • Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

    Jeffrey J. Tosoian;Mufaddal Mamawala;Jonathan I. Epstein;Patricia Landis

  • The prostate: An increasing medical problem

    H. Ballentine Carter;Donald S. Coffey

  • Metabolic Factors Associated with Benign Prostatic Hyperplasia

    J. Kellogg Parsons;H. Ballentine Carter;Alan W. Partin;B. Gwen Windham

  • Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins Experience

    H. Ballentine Carter;Anna Kettermann;Anna Kettermann;Christopher Warlick;E. Jeffrey Metter

  • Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

    Andrew W. Roddam;Naomi E. Allen;Paul Appleby;Timothy J. Key

  • Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.

    Mohamad E. Allaf;Ganesh S. Palapattu;Bruce J. Trock;H. Ballentine Carter

  • Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability

    H. Ballentine Carter;Luigi Ferrucci;Anna Kettermann;Patricia Landis

  • Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

    Rong Na;S. Lilly Zheng;Misop Han;Hongjie Yu

  • Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

    Jonathan I. Epstein;Jonathan I. Epstein;Daniel W. Chan;Daniel W. Chan;Lori J. Sokoll;Lori J. Sokoll;Patrick C. Walsh;Patrick C. Walsh

  • Clinical evidence for and implications of the multistep development of prostate cancer.

    H. Ballentine Carter;Steven Piantadosi;John T. Isaacs

Frequent Co-Authors

Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Alan W. Partin
Alan W. Partin Johns Hopkins University School of Medicine
E. Jeffrey Metter
E. Jeffrey Metter University of Tennessee Health Science Center
Bruce J. Trock
Bruce J. Trock Johns Hopkins University
Stacy Loeb
Stacy Loeb New York University
Patrick C. Walsh
Patrick C. Walsh Johns Hopkins University
Luigi Ferrucci
Luigi Ferrucci National Institutes of Health
Edward M. Schaeffer
Edward M. Schaeffer Northwestern University
Daniel W. Chan
Daniel W. Chan Johns Hopkins University School of Medicine
Elizabeth A. Platz
Elizabeth A. Platz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean following the traditional MD path. Today, a variety of online degrees make it easier to advance or pivot within the healthcare field, offering greater flexibility and affordability.

For nurses seeking advanced clinical and leadership roles, msn to dnp programs online provide a direct route to a Doctor of Nursing Practice, enhancing career prospects and earning potential.

Those interested in pharmaceuticals can prepare for clinical and non-clinical pharmacy roles via online pharmacist programs, which offer comprehensive pharmaceutical education in a flexible format.

Beyond clinical care, the demand for skilled professionals in health data management is growing. An accredited health information management degree online can launch a career managing patient records, compliance, and healthcare IT systems.

Administrative roles such as medical billing and coding remain essential in healthcare organizations. If you’re asking how much is medical billing and coding school, online options provide an affordable, accessible way to enter this high-demand field.

Best Scientists Citing H. Ballentine Carter

Trending Scientists

Recently Published Articles